Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AS703569 and Gemcitabine Combination in Advanced Malignancies

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck KGaA
ClinicalTrials.gov Identifier:
NCT01097512
First received: March 31, 2010
Last updated: January 29, 2014
Last verified: January 2014